Blog
Pharmacovigilance and its Place in the Industry
Pharmacovigilance ensures patients can trust the people handling their healthcare. Learn more about the importance of patient safety and what we’re…
All Results
Blog
Fact Sheet
Risk-Based Approach to Clinical Development
PRA’s risk-based approach to clinical development represents a comprehensive approach to clinical study risk management and includes centralized…
White Paper
Local Representation: What Clinical Trial Sponsors Need to Know
In this white paper, best practices are described as well as required Sponsor/Local Representative agreement areas. It is important that major…
Page
Medical Science Liaisons
PRA’s Medical Science Liaisons (MSLs) are highly skilled and trained scientific resources working for you throughout every step of product…
Fact Sheet
Pharmacovigilance and Patient Safety
PRA provides a comprehensive range of pharmacovigilance solutions for the entire product life cycle. We deliver flexible and customized services with…
White Paper
Sponsor and CRO Pharmacovigilance Alliances
Outsourcing pharmacovigilance activities is a standard business practice in a continuously expanding market segment. In the past, outsourced safety…
Newsletter
Pharmacovigilance Nugget #2 Generating a DSUR - November 2017
A Development Safety Update Report (DSUR) is a periodic regulatory safety report used for drugs under development and for marketed products that are…
Newsletter
Pharmacovigilance Nugget #1 Adjudication - August 2017
Data that has a level of confidence, validity, and reliability is crucial to the success of a clinical trial and to bringing the investigational…